Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaobao Xu
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
Observed institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
ORCID:
0000-0003-0742-9515
Observed ORCID:
0000-0003-0742-9515
OpenAlex ID:
A5083549298
High-resolution characterization of gene function using single-cell CRISPR tiling screen
2021
·
Lu Yang
, Anthony K. N. Chan
, et al.
·
Nature Communications
·
48
PDF
3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia
2021
·
Qiao Liu
, Anthony K. N. Chan
, et al.
·
Leukemia
·
32
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1‐EEF1A1 Axis
2023
·
Mingli Li
, Lu Yang
, et al.
·
Advanced Science
·
30
PDF
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens
2024
·
Nicole M. Mattson
, Anthony K. N. Chan
, et al.
·
Nature Structural & Molecular Biology
·
26
PDF
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery
2024
·
Anthony K.N. Chan
, Li Han
, et al.
·
Science Advances
·
16
Abstract 6234: Targeting integrin alpha V beta 5 heterodimer stability using a novel small molecular inhibitor for tumor suppression
2023
·
Nicole Mattson
, Kazuya Miyashita
, et al.
·
Cancer Research
Abstract 2967: ACTR5 maintains hepatocellular carcinoma via H3K9 epigenetic silencing of CDKN2A
2022
·
Xiaobao Xu
, Lu Yang
, et al.
·
Cancer Research
Abstract 2920: Targeting integrin alpha V beta 5 heterodimer stability using a novel small molecular inhibitor for tumor suppression
2022
·
Nicole Mattson
, Kazuya Miyashita
, et al.
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
152
H-index:
5
I10-index:
5
Year
Topic
Type